COLL
Collegium Pharmaceutical, Inc. Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →
Collegium Pharmaceutical, Inc. (COLL) closed at $35.44 as of 2026-03-20, trading 19.2% above its 200-week moving average of $29.72. The stock moved further from the line this week, up from 16.4% last week. With a 14-week RSI of 20, COLL is in oversold territory.
A big jump in activity this week — 2.4x the usual volume, and the price went up. Significantly more people than usual decided to buy. This kind of surge, especially on a stock already below its 200-week average, can be an early sign that sentiment is shifting.
Over the past 519 weeks of data, COLL has crossed below its 200-week moving average 14 times. On average, these episodes lasted 13 weeks. Historically, investors who bought COLL at the start of these episodes saw an average one-year return of +13.9%.
With a market cap of $1125 million, COLL is a small-cap stock. The company generates a free cash flow yield of 28.6%, which is notably high. Return on equity stands at 23.7%, indicating strong profitability. The stock trades at 3.7x book value.
The company has been aggressively buying back shares, reducing its share count by 6.3% over the past three years.
Over the past 10 years, a hypothetical investment of $100 in COLL would have grown to $186, compared to $370 for the S&P 500. COLL has returned 6.4% annualized vs 14.0% for the index, underperforming the broader market over this period.
Free cash flow has been growing at a 38.8% compound annual rate, with 4 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: COLL vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After COLL Crosses Below the Line?
Across 14 historical episodes, buying COLL when it crossed below its 200-week moving average produced an average return of +12.0% after 12 months (median +31.0%), compared to +14.8% for the S&P 500 over the same periods. 64% of those episodes were profitable after one year. After 24 months, the average return was +40.4% vs +32.4% for the index.
Each line shows $100 invested at the moment COLL crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
COLL has crossed below its 200-week MA 14 times with an average 1-year return of +13.9% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 2016 | Sep 2016 | 24 | 48.5% | -46.1% | +91.2% |
| Oct 2016 | Nov 2017 | 55 | 50.9% | -34.7% | +132.7% |
| Aug 2018 | Oct 2018 | 7 | 12.8% | -31.6% | +110.5% |
| Oct 2018 | Nov 2018 | 4 | 8.7% | -29.5% | +116.1% |
| Dec 2018 | Feb 2019 | 10 | 14.8% | +33.2% | +139.8% |
| Mar 2019 | Nov 2019 | 33 | 37.3% | -9.7% | +124.3% |
| Mar 2020 | Mar 2020 | 1 | 11.2% | +80.3% | +148.5% |
| Jun 2020 | Jun 2020 | 1 | 1.0% | +54.7% | +116.9% |
| Jul 2020 | Aug 2020 | 1 | 5.0% | +57.7% | +124.6% |
| Aug 2021 | Aug 2021 | 1 | 6.3% | +5.9% | +99.7% |
| Nov 2021 | Feb 2022 | 15 | 8.0% | -1.2% | +85.9% |
| Feb 2022 | Mar 2022 | 2 | 8.1% | +50.5% | +98.0% |
| Apr 2022 | Aug 2022 | 15 | 20.3% | +30.7% | +100.8% |
| Aug 2022 | Oct 2022 | 11 | 13.2% | +34.1% | +98.9% |
| Average | 13 | — | +13.9% | — |
Frequently Asked Questions
Is COLL below its 200-week moving average?
No. Collegium Pharmaceutical, Inc. (COLL) is currently 19.2% above its 200-week moving average of $29.72. It would need to fall to $29.72 to cross below the line.
What is COLL's 200-week moving average price?
Collegium Pharmaceutical, Inc.'s 200-week moving average is $29.72 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when COLL drops below its 200-week moving average?
COLL has crossed below its 200-week moving average 14 times in our data. On average, buying at that moment produced a one-year return of +13.9%. These dips have historically been decent entry points. These episodes lasted 13 weeks on average.
Is COLL a good value right now?
Here's what our data says about COLL as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 20 (oversold). Free cash flow yield is 28.6%. Return on equity is 23.7%. Price-to-book is 3.7x. This is not a buy or sell recommendation — always do your own research.
How does COLL compare to the S&P 500?
Over the past 10 years, $100 invested in COLL would have grown to $186, compared to $370 for the S&P 500. That's 6.4% annualized vs 14.0% for the index. COLL has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20